Clinical risk factors of colorectal cancer in patients with serrated polyposis syndrome: A multicentre cohort analysis

Gut

Volumn 66, Issue 2, 2017, Pages 278-284

  Ijspeert, J E G ^a   Rana, S A Q ^b   Atkinson, N S S ^c   Van Herwaarden, Y J ^d   Bastiaansen, B A J ^a   Van Leerdam, M E ^e   Sanduleanu, S ^f   Bisseling, T M ^d   Spaander, M C W ^g   Clark, S K ^b   Meijer, G A ^e   Van Lelyveld, N ^h   Koornstra, J J ⁱ   Nagtegaal, I D ^d   East, J E ^c   Latchford, A ^b   Dekker, E ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ST MARK S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e NETHERLANDS CANCER INSTITUTE   (Netherlands)

^f MAASTRICHT UNIVERSITY   (Netherlands)

^g ERASMUS MEDICAL CENTER   (Netherlands)

^h ST ANTONIUS HOSPITAL   (Netherlands)

ⁱ UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; CANCER GROWTH; CANCER RISK; CARCINOGENESIS; COHORT ANALYSIS; COLON ADENOMA; COLON PERFORATION; COLON POLYP; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; FEMALE; GASTROINTESTINAL DYSPLASIA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NETHERLANDS; PHENOTYPE; POLYPECTOMY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SERRATED POLYPOSIS SYNDROME; SMOKING; UNITED KINGDOM; ADENOMA; ADENOMATOUS POLYPOSIS COLI; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL NEOPLASMS; HEALTH SURVEY; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; VERY ELDERLY; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

ADENOMA; ADENOMATOUS POLYPOSIS COLI; ADULT; AGED; AGED, 80 AND OVER; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SMOKING; UNITED KINGDOM; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 85011369456     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2015-310630     Document Type: Article

References (32)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
2. Zauber AGAAG, Winawer SSJ, O'Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012;67:355-6.
3. Samowitz WS, Albertsen H, Herrick J, et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 2005;129:837-45.
4. Toyota M, Ahuja N, Ohe-Toyota M, et al. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999;96:8681-6.
5. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007;50:113-30.
6. East JE, Saunders BP, Jass JR. Sporadic and syndromic hyperplastic polyps and serrated adenomas of the colon: classification, molecular genetics, natural history, and clinical management. Gastroenterol Clin North Am 2008;37:25-46.
7. Leggett B, Whitehall V. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 2010;138:2088-100.
8. Snover DC. Update on the serrated pathway to colorectal carcinoma. Hum Pathol 2011;42:1-10.
9. Boparai KS, Dekker E, Polak MM, et al. A serrated colorectal cancer pathway predominates over the classic WNT pathway in patients with hyperplastic polyposis syndrome. Am J Pathol 2011;178:2700-7.
10. Snover DC, Ahnen DJ, Burt RW, et al. Serrated polyps of the colon and rectum and serrated polyposis. In: Bosman T, Carneiro F, Hruban R, et al. eds. WHO classification of tumours of the digestive system. Lyon, 2010. 160-5.
11. Rex DK, Ahnen DJ, Baron JA, et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 2012;107:1315-29; Quiz 1314, 1330.
12. Rosty C, Hewett DG, Brown IS, et al. Serrated polyps of the large intestine: current understanding of diagnosis, pathogenesis, and clinical management. J Gastroenterol 2013;48:287-302.
13. East JE, Vieth M, Rex DK. Serrated lesions in colorectal cancer screening: detection, resection, pathology and surveillance. Gut 2015;64:991-1000.
14. Boparai KS, Mathus-Vliegen EMH, Koornstra JJ, et al. Increased colorectal cancer risk during follow-up in patients with hyperplastic polyposis syndrome: a multicentre cohort study. Gut 2010;59:1094-100.
15. Edelstein DL, Axilbund JE, Hylind LM, et al. Serrated polyposis: rapid and relentless development of colorectal neoplasia. Gut 2013;62:404-8.
16. Ferrández A, Samowitz W, DiSario JA, et al. Phenotypic characteristics and risk of cancer development in hyperplastic polyposis: Case series and literature review. Am J Gastroenterol 2004;99:2012-18.
17. Hyman NH, Anderson P, Blasyk H. Hyperplastic polyposis and the risk of colorectal cancer. Dis Colon Rectum 2004;47:2101-4.
18. Rubio CA, Stemme S, Jaramillo E, et al. Hyperplastic polyposis coli syndrome and colorectal carcinoma. Endoscopy 2006;38:266-70.
19. Hazewinkel Y, Tytgat KM, van Eeden S, et al. Incidence of colonic neoplasia in patients with serrated polyposis syndrome who undergo annual endoscopic surveillance. Gastroenterology 2014;147:88-95.
20. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 1997;310:2191-4.
21. Ensari A, Bilezikçi B, Carneiro F, et al. Serrated polyps of the colon: how reproducible is their classification. Virchows Arch 2012;461:495-504.
22. Rau TT, Agaimy A, Gehoff A, et al. Defined morphological criteria allow reliable diagnosis of colorectal serrated polyps and predict polyp genetics. Virchows Arch 2014;464:663-72.
23. Streiner DL. The case of the missing data: methods of dealing with dropouts and other research vagaries. Can J Psychiatry 2002;47:68-75.
24. Abdeljawad K, Vemulapalli KC, Kahi CJ, et al. Sessile serrated polyp prevalence determined by a colonoscopist with a high lesion detection rate and an experienced pathologist. Gastrointest Endosc 2015;81:517-24.
25. Aust DE, Baretton GB. Serrated polyps of the colon and rectum (hyperplastic polyps, sessile serrated adenomas, traditional serrated adenomas, and mixed polyps)-proposal for diagnostic criteria. Virchows Arch 2010;457:291-7.
26. Hassan C, Quintero E, Dumonceau J-M, et al. Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2013;45:842-51.
27. Chow E, Lipton L, Lynch E, et al. Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology 2006;131:30-9.
28. Lage P, Cravo M, Sousa R, et al. Management of Portuguese patients with hyperplastic polyposis and screening of at-risk first-degree relatives: a contribution for future guidelines based on a clinical study. Am J Gastroenterol 2004;99:1779-84.
29. Guarinos C, Sánchez-Fortún C, Rodríguez-Soler M, et al. Clinical subtypes and molecular characteristics of serrated polyposis syndrome. Clin Gastroenterol Hepatol 2013;11:705-11; Quiz e46.
30. Kalady MF, Jarrar A, Leach B, et al. Defining phenotypes and cancer risk in hyperplastic polyposis syndrome. Dis Colon Rectum 2011;54:164-70.
31. Rosty C, Buchanan DD, Walsh MD, et al. Phenotype and Polyp Landscape in Serrated Polyposis Syndrome: a series of 100 patients from genetics clinics. Am J Surg Pathol 2012;36:876-82.
32. Buchanan DD, Sweet K, Drini M, et al. Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics. PLoS ONE 2010;5:1-7.